{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:25:21Z","timestamp":1792445121598,"version":"4.5.0"},"reference-count":318,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.addr.2018.04.007","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T13:14:06Z","timestamp":1522847646000},"page":"3-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":420,"special_numbering":"C","title":["Aptamer chemistry"],"prefix":"10.1016","volume":"134","author":[{"given":"Pascal","family":"R\u00f6thlisberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Hollenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2018.04.007_bb0005","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/ar500432k","article-title":"The chemical space project","volume":"48","author":"Reymond","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nchembio.1199","article-title":"Target identification and mechanism of action in chemical biology and drug discovery","volume":"9","author":"Schenone","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2018.04.007_bb0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.addr.2018.04.007_bb0020","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.04.007_bb0025","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1002\/anie.200701369","article-title":"Forty years of in vitro evolution","volume":"46","author":"Joyce","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2016.06.003","article-title":"The in vitro selection world","volume":"106","author":"Jijakli","year":"2016","journal-title":"Methods"},{"key":"10.1016\/j.addr.2018.04.007_bb0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.tibs.2016.04.010","article-title":"Catalyic DNA: scope, applications, and biochemistry of deoxyribozymes","volume":"41","author":"Silverman","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.addr.2018.04.007_bb0040","doi-asserted-by":"crossref","first-page":"11930","DOI":"10.1002\/anie.201502890","article-title":"The expanded genetic alphabet","volume":"54","author":"Malyshev","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb0045","doi-asserted-by":"crossref","first-page":"20777","DOI":"10.3390\/molecules201119730","article-title":"DNA catalysis: the chemical repertoire of DNAzymes","volume":"20","author":"Hollenstein","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2018.04.007_bb0050","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1021\/acs.accounts.7b00262","article-title":"Discovery and biosensing applications of diverse RNA-cleaving DNAzymes","volume":"50","author":"Liu","year":"2017","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0055","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.3390\/ijms18112430","article-title":"Nucleic acid aptamers: emerging applications in medical imaging, nanotechnology, neurosciences, and drug delivery","volume":"18","author":"R\u00f6thlisberger","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2018.04.007_bb0060","doi-asserted-by":"crossref","first-page":"0076","DOI":"10.1038\/s41570-017-0076","article-title":"Analysis of aptamer discovery and technology","volume":"1","author":"Dunn","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejps.2012.10.014","article-title":"Therapeutic RNA aptamers in clinical trials","volume":"48","author":"Sundaram","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2018.04.007_bb0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2018.04.007_bb0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fchem.2016.00025","article-title":"Selection and biosensor application of aptamers for small molecules","volume":"4","author":"Pfeiffer","year":"2016","journal-title":"Front. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0080","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.addr.2006.07.020","article-title":"Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA","volume":"58","author":"Fattal","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.04.007_bb0085","series-title":"Nucleic Acid Ligands","author":"Tuerk","year":"1991"},{"key":"10.1016\/j.addr.2018.04.007_bb0090","doi-asserted-by":"crossref","first-page":"16643","DOI":"10.3390\/molecules200916643","article-title":"Generation of aptamers with an expanded chemical repertoire","volume":"20","author":"Diafa","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2018.04.007_bb0095","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.addr.2011.10.002","article-title":"Aptamer-conjugated nanomaterials and their applications","volume":"63","author":"Yang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.04.007_bb0100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.addr.2010.03.003","article-title":"Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates","volume":"62","author":"Lee","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.04.007_bb0105","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/nar\/gkn1070","article-title":"A self-cleaving DNA enzyme modified with amines, guanidines and imidazoles operates independently of divalent metal cations (M-2)","volume":"37","author":"Hollenstein","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0110","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1021\/jacs.6b10646","article-title":"Molecular elucidation of disease biomarkers at the interface of chemistry and biology","volume":"139","author":"Zhang","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb0115","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/344467a0","article-title":"Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA","volume":"344","author":"Robertson","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.04.007_bb0120","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.biotechadv.2015.02.008","article-title":"Current approaches in SELEX: an update to aptamer selection technology","volume":"33","author":"Darmostuk","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.addr.2018.04.007_bb0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/mtna.2014.74","article-title":"Aptamer selection technology and recent advances","volume":"4","author":"Blind","year":"2015","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/j.addr.2018.04.007_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/nar\/gng030","article-title":"Analyzing partially randomized nucleic acid pools: straight dope on doping","volume":"31","author":"Knight","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/co300111f","article-title":"Systematic evaluation of the dependence of deoxyribozyme catalysis on random region length","volume":"14","author":"Velez","year":"2012","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.addr.2018.04.007_bb0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1039\/C3CC47108J","article-title":"An ultra-sensitive colorimetric detection of tetracyclines using the shortest aptamer with highly enhanced affinity","volume":"50","author":"Kwon","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb0145","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1021\/bi960038h","article-title":"Recognition of anionic porphyrins by DNA aptamers","volume":"35","author":"Li","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2018.04.007_bb0150","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/nprot.2010.66","article-title":"Development of DNA aptamers using cell-SELEX","volume":"5","author":"Sefah","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2018.04.007_bb0155","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1039\/b807292m","article-title":"Catalytic DNA (deoxyribozymes) for synthetic applications - current abilities and future prospects","volume":"30","author":"Silverman","year":"2008","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb0160","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00239-015-9708-6","article-title":"Analysis of in vitro aptamer selection parameters","volume":"81","author":"McKeague","year":"2015","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.addr.2018.04.007_bb0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fchem.2016.00014","article-title":"Small-molecule binding aptamers: selection strategies, characterization, and applications","volume":"4","author":"Ruscito","year":"2016","journal-title":"Front. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0170","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2018.04.007_bb0175","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1021\/nn507494p","article-title":"Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation","volume":"9","author":"Lao","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2018.04.007_bb0180","first-page":"13","article-title":"Connecting genetic risk to disease end points through the human blood plasma proteome","volume":"8","author":"Suhre","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1089\/nat.2015.0568","article-title":"Aptamers against immunologic targets: diagnostic and therapeutic prospects","volume":"26","author":"Vorobyeva","year":"2016","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2018.04.007_bb0190","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1021\/cr0306743","article-title":"Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy","volume":"107","author":"Famulok","year":"2007","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2018.04.007_bb0195","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.addr.2011.10.002","article-title":"Aptamer-conjugated nanomaterials and their applications","volume":"63","author":"Yang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.04.007_bb0200","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/cmdc.201402163","article-title":"Aptamers as drug delivery vehicles","volume":"9","author":"Kruspe","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.addr.2018.04.007_bb0205","article-title":"DNA aptamer generation by ExSELEX using genetic alphabet expansion with a mini-hairpin DNA stabilization method","author":"Hirao","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.addr.2018.04.007_bb0210","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1074\/jbc.M113.532697","article-title":"Crystal structure of interleukin-6 in complex with a modified nucleic acid ligand","volume":"289","author":"Gelinas","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0215","doi-asserted-by":"crossref","DOI":"10.1021\/ja801510d","article-title":"Selecting aptamers for a glycoprotein through the incorporation of the boronic acid moiety","volume":"130","author":"Li","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb0220","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/ar700142z","article-title":"Complex target SELEX","volume":"41","author":"Shamah","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0225","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.2174\/092986711797189565","article-title":"Improving the stability of aptamers by chemical modification","volume":"18","author":"Wang","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0230","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/nar\/19.4.747","article-title":"Modified deoxyoligonucleotides stable to exonuclease degradation in serum","volume":"19","author":"Shaw","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0235","doi-asserted-by":"crossref","first-page":"14533","DOI":"10.1074\/jbc.271.24.14533","article-title":"Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras","volume":"271","author":"Monia","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0240","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.1093\/nar\/15.24.10507","article-title":"Rate of degradation of alpha -oligodeoxynucleotides and beta -oligodeoxynucleotides in xenopus oocytes - implications for anti-messenger strategies","volume":"15","author":"Cazenave","year":"1987","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0245","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1182\/blood.V81.12.3271.3271","article-title":"In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits","volume":"81","author":"Griffin","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.addr.2018.04.007_bb0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nbt0197-68","article-title":"Potent 2\u2032-amino-, and 2\u2032-fluoro-2\u2032-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor","volume":"15","author":"Pagratis","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/srep18478","article-title":"Architecture of high-affinity unnatural-base DNA aptamers toward pharmaceutical applications","volume":"5","author":"Matsunaga","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.04.007_bb0260","doi-asserted-by":"crossref","first-page":"13471","DOI":"10.1039\/C6CC05576A","article-title":"Rapid characterization of folding and binding interactions with thermolabile ligands by DSC","volume":"52","author":"Harkness","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb0265","article-title":"Development of a thermal-stable structure-switching cocaine-binding aptamer","author":"Shoara","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.addr.2018.04.007_bb0270","doi-asserted-by":"crossref","first-page":"8652","DOI":"10.1021\/bi4010039","article-title":"Quinine binding by the cocaine-binding aptamer. Thermodynamic and hydrodynamic analysis of high-affinity binding of an off-target ligand","volume":"52","author":"Reinstein","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2018.04.007_bb0275","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nbt1023","article-title":"Antidote-mediated control of an anticoagulant aptamer in vivo","volume":"22","author":"Rusconi","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb0280","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/nat.2017.0683","article-title":"Pharmacokinetic properties of DNA aptamers with base modifications","volume":"27","author":"Gupta","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2018.04.007_bb0285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nchembio.277","article-title":"In vivo selection of tumor-targeting RNA motifs","volume":"6","author":"Mi","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2018.04.007_bb0290","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/mtna.2016.27","article-title":"In vivo selection against human colorectal cancer xenografts identifies an aptamer that targets RNA helicase protein DHX9","volume":"5","author":"Mi","year":"2016","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/j.addr.2018.04.007_bb0295","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/mtna.2012.59","article-title":"In vivo SELEX for identification of brain-penetrating aptamers","volume":"2","author":"Cheng","year":"2013","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/j.addr.2018.04.007_bb0300","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1021\/acs.bioconjchem.6b00746","article-title":"Combinatorial screening of DNA aptamers for molecular imaging of HER2 in cancer","volume":"28","author":"Zhu","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0305","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cbpa.2016.08.001","article-title":"The expanding world of DNA and RNA","volume":"34","author":"Chen","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.addr.2018.04.007_bb0310","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-pharmtox-010716-104558","article-title":"Aptamers as therapeutics","volume":"57","author":"Nimjee","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.addr.2018.04.007_bb0315","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.copbio.2017.03.026","article-title":"Customised nucleic acid libraries selection for enhanced aptamer and performance","volume":"48","author":"Pfeiffert","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb0320","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.copbio.2017.04.005","article-title":"DNA polymerases and biotechnological applications","volume":"48","author":"Aschenbrenner","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb0325","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms18081683","article-title":"Chemical modifications of nucleic acid aptamers for therapeutic purposes","volume":"18","author":"Ni","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2018.04.007_bb0330","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/cbic.201700229","article-title":"Synthetic nucleic acid analogues in gene therapy: an update for peptide-oligonucleotide conjugates","volume":"18","author":"Taskova","year":"2017","journal-title":"Chembiochem"},{"key":"10.1016\/j.addr.2018.04.007_bb0335","doi-asserted-by":"crossref","first-page":"14268","DOI":"10.3390\/molecules181114268","article-title":"Synthesis of DNA\/RNA and their analogs via phosphoramidite and H-phosphonate chemistries","volume":"18","author":"Roy","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2018.04.007_bb0340","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb0345","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2015.03.008","article-title":"Antisense oligonucleotides in therapy for neurodegenerative disorders","volume":"87","author":"Evers","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.04.007_bb0350","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/nat.2017.0680","article-title":"Effect of chemical modifications on aptamer stability in serum","volume":"27","author":"Kratschmer","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2018.04.007_bb0355","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/138620708783398331","article-title":"Post-SELEX chemical optimization of a trypanosome-specific RNA aptamer","volume":"11","author":"Adler","year":"2008","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.addr.2018.04.007_bb0360","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ymthe.2017.03.023","article-title":"FDA-approved oligonucleotide therapies in 2017","volume":"25","author":"Stein","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2018.04.007_bb0365","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd1955","article-title":"Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease","volume":"5","author":"Ng","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2018.04.007_bb0370","doi-asserted-by":"crossref","first-page":"20556","DOI":"10.1074\/jbc.273.32.20556","article-title":"2\u2032-fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF(165)) - inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain","volume":"273","author":"Ruckman","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0375","doi-asserted-by":"crossref","first-page":"18902","DOI":"10.1073\/pnas.0509069102","article-title":"A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF(165)","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.04.007_bb0380","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature00963","article-title":"RNA aptamers as reversible antagonists of coagulation factor IXa","volume":"419","author":"Rusconi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.04.007_bb0385","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.106.668434","article-title":"First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology - a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity","volume":"114","author":"Dyke","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2018.04.007_bb0390","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/CIRCULATIONAHA.109.927756","article-title":"First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention","volume":"122","author":"Cohen","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2018.04.007_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2010.10.022","volume":"161","author":"Povsic","year":"2011","journal-title":"Am. Heart J."},{"key":"10.1016\/j.addr.2018.04.007_bb0400","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(15)00515-2","article-title":"Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial","volume":"387","author":"Lincoff","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2018.04.007_bb0405","first-page":"2335","article-title":"Systematic optimization and modification of a DNA aptamer with 2\u2032-O-methyl RNA analogues","volume":"2","author":"Maio","year":"2017","journal-title":"Chem. Sel."},{"key":"10.1016\/j.addr.2018.04.007_bb0410","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/oli.1.2000.10.117","article-title":"Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them?","volume":"10","author":"Eckstein","year":"2000","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.addr.2018.04.007_bb0415","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0165-022X(90)90084-P","article-title":"Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal-fluid","volume":"20","author":"Campbell","year":"1990","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.addr.2018.04.007_bb0420","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/nar\/gki257","article-title":"The effect of chemical modifications on the thermal stability of different G-quadruplex-forming oligonucleotides","volume":"33","author":"Sacca","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0425","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s11426-015-5367-0","article-title":"Adipo8, a high-affinity DNA aptamer, can differentiate among adipocytes and inhibit intracellular lipid accumulation in vitro","volume":"58","author":"Chen","year":"2015","journal-title":"Sci. China: Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0430","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1538-7836.2009.03459.x","article-title":"Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779","volume":"7","author":"Diener","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.addr.2018.04.007_bb0435","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1160\/TH11-12-0889","article-title":"The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease","volume":"108","author":"Jilma-Stohlawetz","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.addr.2018.04.007_bb0440","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/CIRCULATIONAHA.107.724864","article-title":"First-in-human evaluation of anti-von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers","volume":"116","author":"Gilbert","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.addr.2018.04.007_bb0445","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1160\/TH11-02-0069","article-title":"A dose ranging phase I\/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombocytopenic purpura","volume":"106","author":"Jilma-Stohlawetz","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.addr.2018.04.007_bb0450","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/0040-4039(88)85045-7","article-title":"Nucleotide chemistry 22. Synthesis and characterization of dinucleoside phosphorodithioates","volume":"29","author":"Nielsen","year":"1988","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.addr.2018.04.007_bb0455","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1016\/S0960-894X(99)00600-9","article-title":"Aptamers containing thymidine 3\u2032-O-phosphorodithioates: synthesis and binding to nuclear factor-kappa B","volume":"9","author":"Yang","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2018.04.007_bb0460","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chembiol.2004.10.017","article-title":"Direct in vitro selection of a 2\u2032-O-methyl aptamer to VEGF","volume":"12","author":"Burmeister","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.addr.2018.04.007_bb0465","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/mthe.2001.0495","article-title":"Generation of species cross-reactive aptamers using \"toggle\" SELEX","volume":"4","author":"White","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2018.04.007_bb0470","doi-asserted-by":"crossref","first-page":"8052","DOI":"10.1093\/nar\/gkw725","article-title":"Evoking picomolar binding in RNA by a single phosphorodithioate linkage","volume":"44","author":"Abeydeera","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0475","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1039\/a708608c","article-title":"LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition","author":"Singh","year":"1998","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb0480","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1016\/S0040-4039(98)01084-3","article-title":"Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2\u2032-O,4\u2032-C-methyleneribonucleosides","volume":"39","author":"Obika","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.addr.2018.04.007_bb0485","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1039\/a801571f","article-title":"Universality of LNA-mediated high-affinity nucleic acid recognition","author":"Singh","year":"1998","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb0490","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1073\/pnas.97.10.5633","article-title":"Potent and nontoxic antisense oligonucleotides containing locked nucleic acids","volume":"97","author":"Wahlestedt","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.04.007_bb0495","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/oli.2008.0175","article-title":"Naked siLNA-mediated gene silencing of lung bronchoepithelium EGFP expression after intravenous administration","volume":"19","author":"Glud","year":"2009","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.addr.2018.04.007_bb0500","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1093\/nar\/gkh636","article-title":"LNA\/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1","volume":"32","author":"Darfeuille","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0505","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1093\/nar\/gkh862","article-title":"Application of locked nucleic acids to improve aptamer in vivo stability and targeting function","volume":"32","author":"Schmidt","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0510","doi-asserted-by":"crossref","first-page":"11838","DOI":"10.1073\/pnas.0602615103","article-title":"Aptamers evolved from live cells as effective molecular probes for cancer study","volume":"103","author":"Shangguan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.04.007_bb0515","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cbic.200600532","article-title":"Optimization and modifications of aptamers selected from live cancer cell lines","volume":"8","author":"Shangguan","year":"2007","journal-title":"Chembiochem"},{"key":"10.1016\/j.addr.2018.04.007_bb0520","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.bmcl.2014.03.082","article-title":"Improvement of a streptavidin-binding aptamer by LNA-and alpha-l-LNA-substitutions","volume":"24","author":"Jorgensen","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2018.04.007_bb0525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/srep35827","article-title":"Synthetic oligonucleotide antigens modified with locked nucleic acids detect disease specific antibodies","volume":"6","author":"Samuelsen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.04.007_bb0530","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1093\/nar\/gkq996","article-title":"A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia","volume":"39","author":"Mallikaratchy","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0535","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1039\/C5MB00045A","article-title":"Selection of LNA-containing DNA aptamers against recombinant human CD73","volume":"11","author":"Elle","year":"2015","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.addr.2018.04.007_bb0540","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bmcl.2012.12.093","article-title":"2\u2032,4\u2032-BNA\/LNA aptamers: CE-SELEX using a DNA-based library of full-length 2\u2032-O,4\u2032-C-methylene-bridged\/linked bicyclic ribonucleotides","volume":"23","author":"Kasahara","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2018.04.007_bb0545","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1021\/ac400058z","article-title":"Capillary electrophoresis-systematic evolution of ligands by exponential enrichment selection of base- and sugar-modified DNA aptamers: target binding dominated by 2\u2032-O,4\u2032-C-methylene-bridged\/locked nucleic acid primer","volume":"85","author":"Kasahara","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0550","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1021\/bi048393s","article-title":"Hexitol nucleic acid-containing aptamers are efficient ligands of HIV-1 TAR RNA","volume":"44","author":"Kolb","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2018.04.007_bb0555","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1039\/C6MB00538A","article-title":"Biological applications of xeno nucleic acids","volume":"13","author":"Morihiro","year":"2017","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.addr.2018.04.007_bb0560","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0968-0896(94)00143-Q","article-title":"Synthesis and evaluation of oligodeoxynucleotides containing acyclic nucleosides - introduction of 3 novel analogs and a summary","volume":"3","author":"Nielsen","year":"1995","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0565","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1093\/nar\/gkq561","article-title":"Thermodynamics of RNA duplexes modified with unlocked nucleic acid nucleotides","volume":"38","author":"Pasternak","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0570","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/nar\/gkq823","article-title":"Improved thrombin binding aptamer by incorporation of a single unlocked nucleic acid monomer","volume":"39","author":"Pasternak","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0575","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1039\/C5CC02756J","article-title":"Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition","volume":"51","author":"Edwards","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb0580","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1093\/nar\/gkt697","article-title":"G-rich VEGF aptamer with locked and unlocked nucleic acid modifications exhibits a unique G-quadruplex fold","volume":"41","author":"Marusic","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0585","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drudis.2014.09.004","article-title":"Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer therapeutics","volume":"20","author":"Vater","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2018.04.007_bb0590","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nbt0996-1116","article-title":"Mirror-design of l-oligonucleotide ligands binding to l-arginine","volume":"14","author":"Nolte","year":"1996","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb0595","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nbt0996-1112","article-title":"Mirror-image RNA that binds d-adenosine","volume":"14","author":"Klussmann","year":"1996","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb0600","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ncomms7923","article-title":"Crystal structure of a mirror-image l-RNA aptamer (Spiegelmer) in complex with the natural l-protein target CCL2","volume":"6","author":"Oberthur","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb0605","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.addr.2017.07.013","article-title":"Advances in cancer stem cell targeting: how to strike the evil at its root","volume":"120","author":"Putzer","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.04.007_bb0610","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nchem.2517","article-title":"A synthetic molecular system capable of mirror-image genetic replication and transcription","volume":"8","author":"Wang","year":"2016","journal-title":"Nat. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0615","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/nar\/gkx079","article-title":"A thermostable d-polymerase for mirror-image PCR","volume":"45","author":"Pech","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0620","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/BJ20131422","article-title":"Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis","volume":"462","author":"Purschke","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.addr.2018.04.007_bb0625","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1111\/bph.13110","article-title":"A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation","volume":"172","author":"Hoehlig","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2018.04.007_bb0630","doi-asserted-by":"crossref","first-page":"21136","DOI":"10.1074\/jbc.M112.444414","article-title":"A mixed mirror-image DNA\/RNA aptamer inhibits glucagon and acutely improves glucose tolerance in models of type 1 and type 2 diabetes","volume":"288","author":"Vater","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0635","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood-2012-09-456756","article-title":"The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys","volume":"121","author":"Schwoebel","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.addr.2018.04.007_bb0640","doi-asserted-by":"crossref","first-page":"13290","DOI":"10.1021\/ja406634g","article-title":"Binding of a structured d-RNA molecule by an l-RNA aptamer","volume":"135","author":"Sczepanski","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb0645","doi-asserted-by":"crossref","first-page":"16032","DOI":"10.1021\/jacs.5b06696","article-title":"Specific inhibition of MicroRNA processing using l-RNA aptamers","volume":"137","author":"Sczepanski","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb0650","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/cbic.201700362","article-title":"An l-RNA aptamer with expanded chemical functionality that inhibits MicroRNA biogenesis","volume":"18","author":"Kabza","year":"2017","journal-title":"Chembiochem"},{"key":"10.1016\/j.addr.2018.04.007_bb0655","doi-asserted-by":"crossref","first-page":"17715","DOI":"10.1021\/jacs.7b10038","article-title":"Heterochiral DNA strand-displacement Circuits","volume":"139","author":"Kabza","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb0660","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1021\/acs.analchem.5b04170","article-title":"Biostable l-DNAzyme for sensing of metal ions in biological systems","volume":"88","author":"Cui","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0665","doi-asserted-by":"crossref","DOI":"10.1038\/nature13900","article-title":"A cross-chiral RNA polymerase ribozyme","volume":"515","author":"Sczepanski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.04.007_bb0670","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/dmd.106.012401","article-title":"Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100","volume":"35","author":"Yu","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2018.04.007_bb0675","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.04.007_bb0680","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0685","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1007\/s11095-004-7676-4","article-title":"Pharmacokinetics and biodistribution of novel aptamer compositions","volume":"21","author":"Healy","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0690","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/oli.2005.15.183","article-title":"Conjugation to polyethylene glycol polymer promotes aptamer biodistribution to healthy and inflamed tissues","volume":"15","author":"Boomer","year":"2005","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.addr.2018.04.007_bb0695","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0169-409X(02)00180-1","article-title":"Effective drug delivery by PEGylated drug conjugates","volume":"55","author":"Greenwald","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.04.007_bb0700","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/oli.1.2000.10.63","article-title":"Anti-l-selectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo","volume":"10","author":"Watson","year":"2000","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.addr.2018.04.007_bb0705","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1089\/nat.2016.0627","article-title":"A novel PEGylation method for improving the pharmacokinetic properties of anti-interleukin-17A RNA aptamers","volume":"27","author":"Haruta","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2018.04.007_bb0710","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1021\/bc300128r","article-title":"PEGylation and biodistribution of an anti-MUC1 aptamer in MCF-7 tumor-bearing mice","volume":"23","author":"Da Pieve","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0715","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mtna.2015.30","article-title":"Pharmacokinetics of a cholesterol-conjugated aptamer against the hepatitis C virus (HCV) NS5B protein","volume":"4","author":"Lee","year":"2015","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/j.addr.2018.04.007_bb0720","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1128\/JVI.00405-13","article-title":"Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase","volume":"87","author":"Lee","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2018.04.007_bb0725","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0969-8051(99)00103-1","article-title":"Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood","volume":"27","author":"Dougan","year":"2000","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2018.04.007_bb0730","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1021\/bc980002x","article-title":"Liposome anchored vascular endothelial growth factor aptamers","volume":"9","author":"Willis","year":"1998","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0735","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.1016\/j.biomaterials.2014.04.087","article-title":"An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells","volume":"35","author":"Ara","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.04.007_bb0740","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1002\/anie.200901452","article-title":"Reversible cell-specific drug delivery with aptamer-functionalized liposomes","volume":"48","author":"Cao","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb0745","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2016.03.006","article-title":"An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies","volume":"229","author":"Heo","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2018.04.007_bb0750","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1039\/C5SC02631H","article-title":"Using modified aptamers for site specific protein-aptamer conjugations","volume":"7","author":"Wang","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.addr.2018.04.007_bb0755","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/mabi.200900046","article-title":"A hybrid DNA aptamer-dendrimer nanomaterial for targeted cell labeling","volume":"9","author":"Zhou","year":"2009","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.addr.2018.04.007_bb0760","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1039\/C4NR00019F","article-title":"DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics","volume":"6","author":"Latorre","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2018.04.007_bb0765","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1002\/anie.201602702","article-title":"N-heterocyclic carbene-gold(I) complexes conjugated to a leukemia-specific DNA aptamer for targeted drug delivery","volume":"55","author":"Niu","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb0770","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wnan.1438","article-title":"Advances in the development of aptamer drug conjugates for targeted drug delivery","volume":"9","author":"Chen","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb0775","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1021\/acs.bioconjchem.5b00291","article-title":"Aptamer-drug conjugates","volume":"26","author":"Zhu","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0780","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1021\/nl071546n","article-title":"Quantum dot - aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on Bi-fluorescence resonance energy transfer","volume":"7","author":"Bagalkot","year":"2007","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2018.04.007_bb0785","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/cmdc.200800091","article-title":"Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy","volume":"3","author":"Wang","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.addr.2018.04.007_bb0790","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.omtn.2017.10.004","article-title":"An albumin-oligonucleotide assembly for potential combinatorial drug delivery and half-life extension applications","volume":"9","author":"Kuhlmann","year":"2017","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/j.addr.2018.04.007_bb0795","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrg2968","article-title":"Current prospects for RNA interference-based therapies","volume":"12","author":"Davidson","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.addr.2018.04.007_bb0800","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.addr.2015.10.009","article-title":"Current preclinical small interfering RNA (siRNA)-based conjugate systems for RNA therapeutics","volume":"104","author":"Lee","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.04.007_bb0805","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt1223","article-title":"Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras","volume":"24","author":"McNamara","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb0810","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.1560","article-title":"Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors","volume":"27","author":"Dassie","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb0815","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/mtna.2012.41","article-title":"Thermal stability of siRNA modulates aptamer-conjugated siRNA inhibition","volume":"1","author":"Berezhnoy","year":"2012","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/j.addr.2018.04.007_bb0820","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41565-017-0012-z","article-title":"Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression","volume":"13","author":"Pi","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb0825","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1016\/j.biomaterials.2010.02.030","article-title":"Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.04.007_bb0830","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bcmd.2006.11.008","article-title":"LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1","volume":"38","author":"Lebars","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.addr.2018.04.007_bb0835","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/nass\/nrn331","article-title":"Boranophosphate siRNA-aptamer chimeras for tumor-specific downregulation of cancer receptors and modulators","volume":"52","author":"Shaw","year":"2008","journal-title":"Nucleic Acids Symp. Ser."},{"key":"10.1016\/j.addr.2018.04.007_bb0840","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1758-907X-1-4","article-title":"Aptamer-targeted cell-specific RNA interference","volume":"1","author":"Zhou","year":"2010","journal-title":"Silence"},{"key":"10.1016\/j.addr.2018.04.007_bb0845","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.nano.2016.11.015","article-title":"RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery","volume":"13","author":"Pi","year":"2017","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.addr.2018.04.007_bb0850","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/nat.2015.0550","article-title":"Targeting cancer cells using LNA-modified aptamer-siRNA chimeras","volume":"25","author":"Subramanian","year":"2015","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2018.04.007_bb0855","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1021\/acsnano.5b01203","article-title":"Construction of an aptamer\u2013SiRNA chimera-modified tissue-engineered blood vessel for cell-type-specific capture and delivery","volume":"9","author":"Chen","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2018.04.007_bb0860","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biomaterials.2014.08.046","article-title":"Highly stable aptamers selected from a 2\u2032-fully modified fGmH RNA library for targeting biomaterials","volume":"36","author":"Friedman","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.04.007_bb0865","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/nat.2012.0347","article-title":"Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells","volume":"22","author":"Kotula","year":"2012","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2018.04.007_bb0870","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1002\/anie.201405778","article-title":"An aptamer intrinsically comprising 5-fluoro-2\u2032-deoxyuridine for targeted chemotherapy","volume":"53","author":"Kruspe","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb0875","doi-asserted-by":"crossref","first-page":"31103","DOI":"10.1038\/srep31103","article-title":"Fluorescence based aptasensors for the determination of hepatitis B virus e antigen","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.04.007_bb0880","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.bios.2012.09.053","article-title":"A signal-on fluorescent aptasensor based on Tb3+ and structure-switching aptamer for label-free detection of Ochratoxin A in wheat","volume":"41","author":"Zhang","year":"2013","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.addr.2018.04.007_bb0885","doi-asserted-by":"crossref","first-page":"14729","DOI":"10.1038\/s41598-017-15333-5","article-title":"Ratiometric electrochemical aptasensor based on ferrocene and carbon nanofibers for highly specific detection of tetracycline residues","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.04.007_bb0890","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bios.2012.11.013","article-title":"Electrogenerated trisbipyridyl Ru(II)-\/nitrilotriacetic-polypyrene copolymer for the easy fabrication of label-free photoelectrochemical immunosensor and aptasensor: application to the determination of thrombin and anti-cholera toxinantibody","volume":"42","author":"Wenjuan","year":"2013","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.addr.2018.04.007_bb0895","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bios.2017.01.015","article-title":"Progress and challenges in electrochemiluminescent aptasensors","volume":"92","author":"Muzyka","year":"2017","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.addr.2018.04.007_bb0900","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/ac102679r","article-title":"Surface immobilization of structure-switching DNA aptamers on macroporous sol-gel-derived films for solid-phase biosensing applications","volume":"83","author":"Carrasquilla","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0905","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/emm.2016.44","article-title":"Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools","volume":"48","author":"Jo","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.addr.2018.04.007_bb0910","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/BST20120059","article-title":"Quantum dot-nucleic acid\/aptamer bioconjugate-based fluorimetric biosensors","volume":"40","author":"Zhou","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.addr.2018.04.007_bb0915","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/bc500503e","article-title":"Aptamer-conjugated graphene oxide membranes for highly efficient capture and accurate identification of multiple types of circulating tumor cells","volume":"26","author":"Nellore","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0920","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/adhm.201700736","article-title":"Graphene field-effect transistors for the sensitive and selective detection of Escherichia coli using pyrene-tagged DNA aptamer","volume":"6","author":"Wu","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2018.04.007_bb0925","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1039\/C7OB00858A","article-title":"On the enzymatic incorporation of an imidazole nucleotide into DNA","volume":"15","author":"Rothlisberger","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0930","doi-asserted-by":"crossref","first-page":"13031","DOI":"10.1039\/C7CC07207D","article-title":"Facile immobilization of DNA using an enzymatic his-tag mimic","volume":"53","author":"Rothlisberger","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb0935","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1021\/ac048344l","article-title":"Chiral stationary phase based on a biostable l-RNA aptamer","volume":"77","author":"Brumbt","year":"2005","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0940","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1039\/C5AN02468D","article-title":"Noncompetitive affinity assays of glucagon and amylin using mirror-image aptamers as affinity probes","volume":"141","author":"Yi","year":"2016","journal-title":"Analyst"},{"key":"10.1016\/j.addr.2018.04.007_bb0945","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1021\/acs.analchem.6b02871","article-title":"Biostable l-DNA-templated aptamer-silver nanoclusters for cell-type-specific imaging at physiological temperature","volume":"88","author":"Han","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb0950","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1021\/ja302197x","article-title":"Ligand-dependent exponential amplification of a self-replicating l-RNA enzyme","volume":"134","author":"Olea","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb0955","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2018.04.007_bb0960","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1039\/C5AN01347J","article-title":"Analysis of ATP and AMP binding to a DNA aptamer and its imidazole-tethered derivatives by surface plasmon resonance","volume":"140","author":"Zhao","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.addr.2018.04.007_bb0965","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1021\/ja4012222","article-title":"Efficacy of base-modification on target binding of small molecule DNA aptamers","volume":"135","author":"Imaizumi","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb0970","doi-asserted-by":"crossref","first-page":"16337","DOI":"10.1038\/srep16337","article-title":"A universal base in a specific role: tuning up a thrombin aptamer with 5-nitroindole","volume":"5","author":"Tsvetkov","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.04.007_bb0975","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1039\/b923462d","article-title":"Pyrrolo-dC based fluorescent aptasensors for the molecular recognition of targets","volume":"46","author":"Li","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb0980","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/nar\/gkh307","article-title":"Using pyrrolo-deoxycytosine to probe RNA\/DNA hybrids containing the human immunodeficiency virus type-1 3\u2032 polypurine tract","volume":"32","author":"Dash","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb0985","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1039\/C3SC52625A","article-title":"Electronic tuning of fluorescent 8-aryl-guanine probes for monitoring DNA duplex-quadruplex exchange","volume":"5","author":"Sproviero","year":"2014","journal-title":"Chem. Sci."},{"key":"10.1016\/j.addr.2018.04.007_bb0990","doi-asserted-by":"crossref","first-page":"16829","DOI":"10.1039\/C5CC07154B","article-title":"Dual fluorescent deoxyguanosine mimics for FRET detection of G-quadruplex folding","volume":"51","author":"Blanchard","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb0995","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1021\/acschembio.6b00437","article-title":"A simple molecular rotor for defining nucleoside environment within a DNA aptamer\u2013protein complex","volume":"11","author":"Cservenyi","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.addr.2018.04.007_bb1000","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1002\/(SICI)1521-3773(19981102)37:20<2872::AID-ANIE2872>3.0.CO;2-5","article-title":"Expanding the potential of DNA for binding and catalysis: highly functionalized dUTP derivatives that are substrates for thermostable DNA polymerases","volume":"37","author":"Sakthivel","year":"1998","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb1005","doi-asserted-by":"crossref","first-page":"15071","DOI":"10.1021\/ja051725b","article-title":"A versatile toolbox for variable DNA functionalization at high density","volume":"127","author":"Jager","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1010","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1002\/chem.201103270","article-title":"Synthesis of aldehyde-linked nucleotides and DNA and their bioconjugations with lysine and peptides through reductive amination","volume":"18","author":"Raindlov\u00e1","year":"2012","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.addr.2018.04.007_bb1015","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1039\/c3ob40842f","article-title":"Deoxynucleoside triphosphates bearing histamine, carboxylic acid, and hydroxyl residues \u2013 synthesis and biochemical characterization","volume":"11","author":"Hollenstein","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1020","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1039\/C6OB02335E","article-title":"Systematic study of constraints imposed by modified nucleoside triphosphates with protein-like side chains for use in in vitro selection","volume":"15","author":"Wang","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1039\/C2OB26881G","article-title":"Synthesis of nucleosides and dNTPs bearing oligopyridine ligands linked through an octadiyne tether, their incorporation into DNA and complexation with transition metal cations","volume":"11","author":"Kalachova","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1030","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/chem.200801538","article-title":"Base-modified DNA labeled by Ru(bpy)(3) (2+) and Os(bpy)(3) (2+) complexes: construction by polymerase incorporation of modified nucleoside triphosphates, electrochemical and luminescent properties, and applications","volume":"15","author":"Vrabel","year":"2009","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.addr.2018.04.007_bb1035","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1021\/ja017193q","article-title":"Redox-active metal-containing nucleotides: synthesis, tunability, and enzymatic incorporation into DNA","volume":"124","author":"Weizman","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1040","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1016\/j.bmcl.2017.09.064","article-title":"Carborane-linked 2\u2032-deoxyuridine 5\u2032-O-triphosphate as building block for polymerase synthesis of carborane-modified DNA","volume":"27","author":"Balintova","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2018.04.007_bb1045","doi-asserted-by":"crossref","first-page":"13320","DOI":"10.1002\/chem.201201662","article-title":"Synthesis of deoxynucleoside triphosphates that include proline, urea, or sulfonamide groups and their polymerase incorporation into DNA","volume":"18","author":"Hollenstein","year":"2012","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.addr.2018.04.007_bb1050","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/asia.201700374","article-title":"Enzymatic synthesis of 7,5-Bicyclo-DNA oligonucleotides","volume":"12","author":"Diafa","year":"2017","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.addr.2018.04.007_bb1055","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1093\/nar\/gkg833","article-title":"Recognition of threosyl nucleotides by DNA and RNA polymerases","volume":"31","author":"Kempeneers","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1060","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/anie.201105717","article-title":"Barcoded nucleotides","volume":"51","author":"Baccaro","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb1065","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1039\/C5CC01387A","article-title":"DNA polymerase-catalyzed incorporation of nucleotides modified with a G-quadruplex-derived DNAzyme","volume":"51","author":"Verga","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb1070","doi-asserted-by":"crossref","first-page":"10131","DOI":"10.1002\/anie.201604641","article-title":"Sequence-specific incorporation of enzyme-nucleotide chimera by DNA polymerases","volume":"55","author":"Welter","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb1075","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/bc400149q","article-title":"Scope and limitations of the nicking enzyme amplification reaction for the synthesis of base-modified oligonucleotides and primers for PCR","volume":"24","author":"Menova","year":"2013","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1080","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.copbio.2017.04.004","article-title":"Engineering and application of polymerases for synthetic genetics","volume":"48","author":"Houlihan","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb1085","doi-asserted-by":"crossref","first-page":"9914","DOI":"10.1021\/jo5020799","article-title":"Synthesis of base-modified 2\u2032-deoxyribonucleoside triphosphates and their use in enzymatic synthesis of modified DNA for applications in bioanalysis and chemical biology","volume":"79","author":"Hocek","year":"2014","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1090","doi-asserted-by":"crossref","first-page":"15856","DOI":"10.1002\/anie.201609007","article-title":"2-substituted dATP derivatives as building blocks for polymerase-catalyzed synthesis of DNA modified in the minor groove","volume":"55","author":"Matyasovsky","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb1095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fchem.2016.00018","article-title":"Modified nucleoside triphosphates for in-vitro selection techniques","volume":"4","author":"Dellafiore","year":"2016","journal-title":"Front. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/mtna.2014.49","article-title":"Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents","volume":"3","author":"Rohloff","year":"2014","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/j.addr.2018.04.007_bb1105","doi-asserted-by":"crossref","first-page":"8706","DOI":"10.1074\/jbc.M113.532580","article-title":"Chemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor","volume":"289","author":"Gupta","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1110","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1093\/nar\/22.14.2817","article-title":"The application of a modified nucleotide in aptamer selection - novel thrombin aptamers containing 5-(1-pentynyl)-2\u2032-deoxyuridine","volume":"22","author":"Latham","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1115","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1021\/ja908035g","article-title":"Expanding the chemistry of DNA for in vitro selection","volume":"132","author":"Vaught","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41467-017-00864-2","article-title":"Structural basis for IL-1 alpha recognition by a modified DNA aptamer that specifically inhibits IL-1 alpha signaling","volume":"8","author":"Ren","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb1125","doi-asserted-by":"crossref","first-page":"19971","DOI":"10.1073\/pnas.1213933109","article-title":"Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets","volume":"109","author":"Davies","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.04.007_bb1130","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.str.2015.03.027","article-title":"Non-helical DNA triplex forms a unique aptamer scaffold for high affinity recognition of nerve growth factor","volume":"23","author":"Jarvis","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.addr.2018.04.007_bb1135","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1073\/pnas.1507719112","article-title":"Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy","volume":"112","author":"Hathout","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.04.007_bb1140","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1074\/mcp.M113.032136","article-title":"Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan(TM)) platform\u204e","volume":"13","author":"Webber","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.addr.2018.04.007_bb1145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41598-017-14755-5","article-title":"Assessment of variability in the SOMAscan assay","volume":"7","author":"Candia","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.04.007_bb1150","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1073\/pnas.1615475114","article-title":"Selection of DNA aptamers with two modified bases","volume":"114","author":"Gawande","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.04.007_bb1155","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1039\/C6OB02451C","article-title":"Whole cell-SELEX of aptamers with a tyrosine-like side chain against live bacteria","volume":"15","author":"Renders","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1160","doi-asserted-by":"crossref","first-page":"9781","DOI":"10.1021\/ja9816436","article-title":"Quantitative analysis of receptors for adenosine nucleotides obtained via in vitro selection from a library incorporating a cationic nucleotide analog","volume":"121","author":"Battersby","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1165","doi-asserted-by":"crossref","first-page":"8842","DOI":"10.1021\/bi027354i","article-title":"A novel, modification-dependent ATP-binding aptamer selected from an RNA library incorporating a cationic functionality","volume":"42","author":"Vaish","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2018.04.007_bb1170","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1021\/ja067098n","article-title":"Modified DNA aptamer that binds the (R)-Isomer of a thalidomide derivative with high enantioselectivity","volume":"129","author":"Shoji","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/srep42716","article-title":"Selection, characterization and application of artificial DNA aptamer containing appended bases with sub-nanomolar affinity for a salivary biomarker","volume":"7","author":"Minagawa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2018.04.007_bb1180","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nchembio.1685","article-title":"Recent strategies targeting HIV glycans in vaccine design","volume":"10","author":"Horiya","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.addr.2018.04.007_bb1185","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.bmcl.2017.01.009","article-title":"New synthetic route to ethynyl-dUTP: a means to avoid formation of acetyl and chloro vinyl base-modified triphosphates that could poison SELEX experiments","volume":"27","author":"R\u00f6thlisberger","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2018.04.007_bb1190","doi-asserted-by":"crossref","first-page":"11238","DOI":"10.1002\/anie.201105555","article-title":"Multivalent glycocluster design through directed evolution","volume":"50","author":"MacPherson","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb1195","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/ja411212q","article-title":"High temperature SELMA: evolution of DNA-supported oligomannose clusters which are tightly recognized by HIV bnAb 2G12","volume":"136","author":"Temme","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1200","doi-asserted-by":"crossref","first-page":"17291","DOI":"10.1002\/chem.201303848","article-title":"Directed evolution of 2G12-targeted nonamannose glycoclusters by SELMA","volume":"19","author":"Temme","year":"2013","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.addr.2018.04.007_bb1205","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1021\/ja500678v","article-title":"Directed evolution of multivalent glycopeptides tightly recognized by HIV antibody 2G12","volume":"136","author":"Horiya","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1210","doi-asserted-by":"crossref","first-page":"10971","DOI":"10.1002\/anie.201503652","article-title":"A versatile approach towards nucleobase-modified aptamers","volume":"54","author":"Tolle","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb1215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/acscombsci.6b00059","article-title":"Generation of synthetic copolymer libraries by combinatorial assembly on nucleic acid templates","volume":"18","author":"Kong","year":"2016","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.addr.2018.04.007_bb1220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/ja311331m","article-title":"DNA ligase-mediated translation of DNA into densely functionalized nucleic acid polymers","volume":"135","author":"Hili","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1225","doi-asserted-by":"crossref","first-page":"13164","DOI":"10.1002\/anie.201607538","article-title":"Enzymatic synthesis of sequence-defined synthetic nucleic acid polymers with diverse functional groups","volume":"55","author":"Kong","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb1230","doi-asserted-by":"crossref","first-page":"13977","DOI":"10.1021\/jacs.7b07241","article-title":"In vitro selection of diversely functionalized aptamers","volume":"139","author":"Kong","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1235","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1016\/j.bmcl.2012.03.056","article-title":"Enzymatic synthesis of 8-vinyl- and 8-styryl-2\u2032-deoxyguanosine modified DNA-novel fluorescent molecular probes","volume":"22","author":"Holzberger","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2018.04.007_bb1240","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1021\/acs.accounts.5b00544","article-title":"Structural insights into the processing of nucleobase-modified nucleotides by DNA polymerases","volume":"49","author":"Hottin","year":"2016","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1245","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41557-018-0008-9","article-title":"Evolution of sequence-defined highly functionalized nucleic acid polymers","volume":"10","author":"Chen","year":"2018","journal-title":"Nat. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1250","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1021\/bi101915z","article-title":"Unlocking the sugar \"steric gate\" of DNA polymerases","volume":"50","author":"Brown","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2018.04.007_bb1255","doi-asserted-by":"crossref","first-page":"11509","DOI":"10.1073\/pnas.92.25.11509","article-title":"Isolation of virus-neutralizing RNAs from a large pool of random sequences","volume":"92","author":"Pan","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.04.007_bb1260","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nbt0197-68","article-title":"Potent 2\u2032-amino-, and 2\u2032-fluoro-2\u2032-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor","volume":"15","author":"Pagratis","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb1265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chembiol.2004.10.017","article-title":"Direct in vitro selection of a 2\u2032-O-methyl aptamer to VEGF","volume":"12","author":"Burmeister","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.addr.2018.04.007_bb1270","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/oli.2006.16.337","article-title":"2\u2032-deoxy purine, 2\u2032-O-methyl pyrimidine (dRmY) aptamers as candidate therapeutics","volume":"16","author":"Burmeister","year":"2006","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.addr.2018.04.007_bb1275","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.1021\/bi00036a009","article-title":"Potent 2\u2032-amino-2\u2032-deoxypyrimidine RNA inhibitors of basic fibroblast growth-factor","volume":"34","author":"Jellinek","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2018.04.007_bb1280","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1093\/nar\/22.24.5229","article-title":"Modified rna sequence pools for in-vitro selection","volume":"22","author":"Lin","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1285","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nchem.2493","article-title":"Evolution of thermophilic DNA polymerases for the recognition and amplification of C2\u2032-modified DNA","volume":"8","author":"Chen","year":"2016","journal-title":"Nat. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1290","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1021\/jacs.6b13132","article-title":"Selection of 2\u2032-fluoro-modified aptamers with optimized properties","volume":"139","author":"Thirunavukarasu","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1295","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.1039\/C7SC03747C","article-title":"Evolved polymerases facilitate selection of fully 2\u2032-OMe-modified aptamers","volume":"8","author":"Liu","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.addr.2018.04.007_bb1300","doi-asserted-by":"crossref","first-page":"14046","DOI":"10.1002\/anie.201707367","article-title":"Enzymatic synthesis, amplification, and application of DNA with a functionalized backbone","volume":"56","author":"Chen","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb1305","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1021\/acscentsci.5b00259","article-title":"Bright fluorescent nanotags from bottlebrush polymers with DNA-tipped bristles","volume":"1","author":"Fouz","year":"2015","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.addr.2018.04.007_bb1310","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1093\/nar\/28.18.3625","article-title":"2\u2032-Deoxy-2\u2032-fluoro-beta-d-arabinonucleosides and oligonucleotides (2\u2032 F-ANA): synthesis and physicochemical studies","volume":"28","author":"Wilds","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1315","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1021\/ja109817p","article-title":"Energetically important C-H center dot center dot center dot F-C pseudohydrogen bonding in water: evidence and application to rational design of oligonucleotides with high binding affinity","volume":"133","author":"Anzahaee","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1320","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/nar\/gkl033","article-title":"Improvements in siRNA properties mediated by 2\u2032-deoxy-2\u2032-fluoro-beta-d-arabinonucleic acid (FANA)","volume":"34","author":"Dowler","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1325","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1093\/nar\/gkm520","article-title":"G-quadruplex induced stabilization by 2\u2032-deoxy-2\u2032-fluoro-d-arabinonucleic acids (2'F-ANA)","volume":"35","author":"Peng","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1330","first-page":"1619","article-title":"Mapping the affinity landscape of thrombin-binding aptamers on 2\u2032 F-ANA\/DNA chimeric G-Quadruplex microarrays","volume":"45","author":"Lietard","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1335","doi-asserted-by":"crossref","DOI":"10.1021\/ja069100g","article-title":"Polymerase-directed synthesis of 2\u2032-deoxy-2\u2032-fluoro-beta-d-arabinonucleic acids","volume":"129","author":"Peng","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1340","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1139\/v08-089","article-title":"Probing DNA polymerase activity with stereoisomeric 2\u2032-fluoro-beta-d-arabinose (2\u2032 F-araNTPs) and 2\u2032-fluoro-beta-d-ribose (2\u2032 F-rNTPs) nucleoside 5-triphosphates","volume":"86","author":"Peng","year":"2008","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1345","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1126\/science.1217622","article-title":"Synthetic genetic polymers capable of heredity and evolution","volume":"336","author":"Pinheiro","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.addr.2018.04.007_bb1350","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature13982","article-title":"Catalysts from synthetic genetic polymers","volume":"518","author":"Taylor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.04.007_bb1355","first-page":"9587","article-title":"Selection of 2\u2032-deoxy-2\u2032-fluoroarabinonucleotide (FANA) aptamers that bind HIV-1 reverse transcriptase with picomolar affinity","volume":"43","author":"Ferreira-Bravo","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1360","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cbdv.200900083","article-title":"Toward safe genetically modified organisms through the chemical diversification of nucleic acids","volume":"6","author":"Herdewijn","year":"2009","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.addr.2018.04.007_bb1365","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cbpa.2012.05.198","article-title":"The XNA world: progress towards replication and evolution of synthetic genetic polymers","volume":"16","author":"Pinheiro","year":"2012","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.addr.2018.04.007_bb1370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cbdv.200900185","article-title":"Nucleic acids with a six-membered \u2018carbohydrate\u2019 mimic in the backbone","volume":"7","author":"Herdewijn","year":"2010","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.addr.2018.04.007_bb1375","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/chem.19970030118","article-title":"1\u2032,5\u2032-anhydrohexitol oligonucleotides: synthesis, base pairing and recognition by regular oligodeoxyribonucleotides and oligoribonucleotides","volume":"3","author":"Hendrix","year":"1997","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.addr.2018.04.007_bb1380","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1093\/nar\/29.15.3154","article-title":"Reverse transcriptase incorporation of 1,5-anhydrohexitol nucleotides","volume":"29","author":"Vastmans","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1385","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/cbic.201600349","article-title":"Structural insights into conformation differences between DNA\/TNA and RNA\/TNA chimeric duplexes","volume":"17","author":"Anosova","year":"2016","journal-title":"Chembiochem"},{"key":"10.1016\/j.addr.2018.04.007_bb1390","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.bmcl.2016.03.118","article-title":"Evaluating TNA stability under simulated physiological conditions","volume":"26","author":"Culbertson","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2018.04.007_bb1395","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1021\/ja511481n","article-title":"DNA polymerase-mediated synthesis of unbiased threose nucleic acid (TNA) polymers requires 7-deazaguanine to suppress G:G mispairing during TNA transcription","volume":"137","author":"Dunn","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1400","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nchem.1241","article-title":"Darwinian evolution of an alternative genetic system provides support for TNA as an RNA progenitor","volume":"4","author":"Yu","year":"2012","journal-title":"Nat. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1405","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ncomms11235","article-title":"A general strategy for expanding polymerase function by droplet microfluidics","volume":"7","author":"Larsen","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb1410","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1093\/nar\/gkx368","article-title":"Synthesis and polymerase activity of a fluorescent cytidine TNA triphosphate analogue","volume":"45","author":"Mei","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1415","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41467-017-02014-0","article-title":"Structural basis for TNA synthesis by an engineered TNA polymerase","volume":"8","author":"Chim","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb1420","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1021\/acs.orglett.7b02099","article-title":"A gram-scale HPLC-free synthesis of TNA triphosphates using an iterative phosphorylation strategy","volume":"19","author":"Sau","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.addr.2018.04.007_bb1425","doi-asserted-by":"crossref","DOI":"10.1039\/C7CC09130C","article-title":"Expanding the chemical diversity of TNA with tUTP derivatives that are substrates for a TNA polymerase","author":"Mei","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb1430","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1093\/nar\/gki578","article-title":"New NTP analogs: the synthesis of 4\u2032-thioUTP and 4\u2032-thioCTP and their utility for SELEX","volume":"33","author":"Kato","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1435","doi-asserted-by":"crossref","first-page":"9450","DOI":"10.1016\/j.bmc.2008.09.048","article-title":"Investigations toward the selection of fully-modified 4\u2032-thioRNA aptamers: optimization of in vitro transcription steps in the presence of 4\u2032-thioNTPs","volume":"16","author":"Minakawa","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1440","first-page":"529","article-title":"PCR amplification of 4\u2032-ThioDNA using 2\u2032-deoxy-4\u2032-thionucleoside 5\u2032-triphosphates","volume":"2","author":"Kojima","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.addr.2018.04.007_bb1445","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/nat.2014.0506","article-title":"Phosphorothioates, essential components of therapeutic oligonucleotides","volume":"24","author":"Eckstein","year":"2014","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2018.04.007_bb1450","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7150\/thno.21342","article-title":"A novel DNA aptamer for dual targeting of polymorphonuclear myeloid-derived suppressor cells and tumor cells","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2018.04.007_bb1455","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2017.09.038","article-title":"Thioaptamer targeted discoidal microparticles increase self-immunity and reduce Mycobacterium tuberculosis burden in mice","volume":"266","author":"Leonard","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2018.04.007_bb1460","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/nar\/30.6.1401","article-title":"Boron-containing aptamers to ATP","volume":"30","author":"Lato","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1465","doi-asserted-by":"crossref","first-page":"11930","DOI":"10.1002\/anie.201502890","article-title":"The expanded genetic alphabet","volume":"54","author":"Malyshev","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb1470","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature24031","article-title":"Expanding and reprogramming the genetic code","volume":"550","author":"Chin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.04.007_bb1475","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nchem.1117","article-title":"Reversible bond formation enables the replication and amplification of a crosslinking salen complex as an orthogonal base pair","volume":"3","author":"Kaul","year":"2011","journal-title":"Nat. Chem."},{"key":"10.1016\/j.addr.2018.04.007_bb1480","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/cbic.201300634","article-title":"Polymerase recognition of a Watson-crick-like metal-mediated base pair: purine-2,6-dicarboxylate center dot copper(II)center dot pyridine","volume":"14","author":"Kim","year":"2013","journal-title":"Chembiochem"},{"key":"10.1016\/j.addr.2018.04.007_bb1485","doi-asserted-by":"crossref","DOI":"10.1002\/chem.201703518","article-title":"Metal-mediated base pairs: from characterization to application","volume":"23","author":"Jash","year":"2017","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.addr.2018.04.007_bb1490","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature13314","article-title":"A semi-synthetic organism with an expanded genetic alphabet","volume":"509","author":"Malyshev","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.04.007_bb1495","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1073\/pnas.1616443114","article-title":"A semisynthetic organism engineered for the stable expansion of the genetic alphabet","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.04.007_bb1500","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nature24659","article-title":"A semi-synthetic organism that stores and retrieves increased genetic information","volume":"551","author":"Zhang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.04.007_bb1505","doi-asserted-by":"crossref","first-page":"12000","DOI":"10.1002\/anie.201704190","article-title":"Structural basis for expansion of the genetic alphabet with an artificial nucleobase pair","volume":"56","author":"Betz","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb1510","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/nar\/gkr1068","article-title":"Highly specific unnatural base pair systems as a third base pair for PCR amplification","volume":"40","author":"Yamashige","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1515","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.2556","article-title":"Generation of high-affinity DNA aptamers using an expanded genetic alphabet","volume":"31","author":"Kimoto","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb1520","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1021\/jacs.6b10767","article-title":"High-affinity DNA aptamer generation targeting von Willebrand factor A1-domain by genetic alphabet expansion for systematic evolution of ligands by exponential enrichment using two types of libraries composed of five different bases","volume":"139","author":"Matsunaga","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1525","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/acssynbio.6b00224","article-title":"Biophysics of artificially expanded genetic information systems. Thermodynamics of DNA duplexes containing matches and mismatches involving 2-amino-3-nitropyridin-6-one (Z) and imidazo 1,2-a-1,3,5-triazin-4(8H)one (P)","volume":"6","author":"Wang","year":"2017","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.addr.2018.04.007_bb1530","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1021\/acs.accounts.6b00655","article-title":"Toward an expanded genome: structural and computational characterization of an artificially expanded genetic information system","volume":"50","author":"Richards","year":"2017","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1535","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/anie.200905173","article-title":"Expanded genetic alphabets in the polymerase chain reaction","volume":"49","author":"Yang","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb1540","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1073\/pnas.1311778111","article-title":"In vitro selection with artificial expanded genetic information systems","volume":"111","author":"Sefah","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2018.04.007_bb1545","doi-asserted-by":"crossref","first-page":"15105","DOI":"10.1021\/ja204910n","article-title":"Amplification, mutation, and sequencing of a six-letter synthetic genetic system","volume":"133","author":"Yang","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1550","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1021\/jacs.5b02251","article-title":"Evolution of functional six-nucleotide DNA","volume":"137","author":"Zhang","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2018.04.007_bb1555","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.1002\/anie.201605058","article-title":"Aptamers against cells overexpressing glypican 3 from expanded genetic systems combined with cell engineering and laboratory evolution","volume":"55","author":"Zhang","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2018.04.007_bb1560","first-page":"9565","article-title":"Laboratory evolution of artificially expanded DNA gives redesignable aptamers that target the toxic form of anthrax protective antigen","volume":"44","author":"Biondi","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2018.04.007_bb1565","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1021\/bi400558c","article-title":"Directed evolution of polymerases to accept nucleotides with nonstandard hydrogen bond patterns","volume":"52","author":"Laos","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2018.04.007_bb1570","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1101\/cshperspect.a023770","article-title":"Alternative Watson-Crick synthetic genetic systems","volume":"8","author":"Benner","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.addr.2018.04.007_bb1575","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.3300","article-title":"Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning","volume":"33","author":"Alipanahi","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2018.04.007_bb1580","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1021\/co5000272","article-title":"Magnetic-assisted rapid aptamer selection (MARAS) for generating high-affinity DNA aptamer using rotating magnetic fields","volume":"16","author":"Lai","year":"2014","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.addr.2018.04.007_bb1585","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1039\/C6CC09991B","article-title":"DNA display of folded RNA libraries enabling RNA-SELEX without reverse transcription","volume":"53","author":"MacPherson","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2018.04.007_bb1590","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1021\/ja003290s","article-title":"Bridging the gap between proteins and nucleic acids: a metal-independent RNAseA mimic with two protein-like functionalities","volume":"123","author":"Perrin","year":"2001","journal-title":"J. Am. Chem. Soc."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X18300590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X18300590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T14:56:47Z","timestamp":1720191407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X18300590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":318,"alternative-id":["S0169409X18300590"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2018.04.007","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aptamer chemistry","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2018.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}